Neuropeptide S promotes wakefulness through activation of the posterior hypothalamic histaminergic and orexinergic neurons

Neuroscience

Volumn 207, Issue , 2012, Pages 218-226

  Zhao, P ^a   Shao, Y F ^a   Zhang, M ^a   Fan, K ^a   Kong, X P ^a   Wang, R ^a   Hou, Y P ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

C Fos; Cortical activation; Histamine neuron; Neuropeptide S; Orexin neuron; Sleep waking states

Indexed keywords

HISTAMINE; MESSENGER RNA; NEUROPEPTIDE S; NEUROPEPTIDE S RECEPTOR; OREXIN; PROTEIN C FOS; RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; BRAIN FORNIX; BRAIN NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ELECTROENCEPHALOGRAPHY; EX VIVO STUDY; HISTAMINERGIC NEURON; IMMUNOHISTOCHEMISTRY; LATERAL HYPOTHALAMUS; MALE; NERVE CELL; NONHUMAN; OREXINERGIC NEURON; PEPTIDE ANALYSIS; PERIFORNICAL NUCLEUS; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REM SLEEP; SLEEP TIME; SLOW WAVE SLEEP; TUBEROMAMMILLARY NUCLEUS; WAKEFULNESS;

ANIMALS; HISTAMINE; HYPOTHALAMUS, POSTERIOR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEURONS; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; WAKEFULNESS;

EID: 84862799992     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.01.022     Document Type: Article

References (42)

1. Adamantidis A., Carter M.C., de Lecea L. Optogenetic deconstruction of sleep-wake circuitry in the brain. Front Mol Neurosci 2010, 2:31.
2. Agis H., Krauth M.T., Böhm A., Mosberger I., Müllauer L., Simonitsch-Klupp I., Walls A.F., Horny H.P., Valent P. Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders. Am J Clin Pathol 2006, 125:273-281.
3. Anaclet C., Parmentier R., Ouk K., Guidon G., Buda C., Sastre J.P., Akaoka H., Sergeeva O.A., Yanagisawa M., Ohtsu H., Franco P., Haas H.L., Lin J.S. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009, 29:14423-14438.
4. Bayer L., Eggermann E., Serafin M., Saint-Mleux B., Machard D., Jones B., Mühlethaler M. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 2001, 14:1571-1575.
5. Chang M., Peng Y.L., Dong S.L., Han R.W., Li W., Yang D.J., Chen Q., Wang R. Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor. Regul Pept 2005, 130:116-122.
6. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
7. Clark S.D., Duangdao D.M., Schulz S., Zhang L., Liu X., Xu Y.L., Reinscheid R.K. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry. J Comp Neurol 2011, 519:1867-1893.
8. Dragunow M., Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 1989, 29:261-265.
9. Eriksson K.S., Sergeeva O., Brown R.E., Haas H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001, 21:9273-9279.
10. Gottlieb D.J., O'Connor G.T., Wilk J.B. Genome-wide association of sleep and circadian phenotypes. BMC Med Genet 2007, 8(Suppl 1):S9.
11. Guerrini R., Salvadori S., Rizzi A., Regoli D., Calo G. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Med Res Rev 2010, 30:751-777.
12. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol Rev 2008, 88:1183-1241.
13. Han R.W., Yin X.Q., Chang M., Peng Y.L., Li W., Wang R. Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-d-aspartate receptor antagonist in mice. Neurosci Lett 2009, 455:74-77.
14. Jones B.E. Paradoxical REM sleep promoting and permitting neuronal networks. Arch Ital Biol 2004, 142:379-396.
15. Jungling K., Seidenbecher T., Sosulina L., Lesting J., Sangha S., Clark S.D., Okamura N., Duangdao D.M., Xu Y.L., Reinscheid R.K., Pape H.C. Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 2008, 59:298-310.
16. Kallupi M., Cannella N., Economidou D., Ubaldi M., Ruggeri B., Weiss F., Massi M., Marugan J., Heilig M., Bonnavion P., de Lecea L., Ciccocioppo R. Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system. Proc Natl Acad Sci U S A 2010, 107:19567-19572.
17. Kushikata T., Yoshida H., Kudo M., Salvadori S., Calo G., Hirota K. The effects of neuropeptide S on general anesthesia in rats. Anesth Analg 2011, 112:845-849.
18. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005, 25:6716-6720.
19. Li W., Chang M., Peng Y.L., Gao Y.H., Zhang J.N., Han R.W., Wang R. Neuropeptide S produces antinociceptive effects at the supraspinal level in mice. Regul Pept 2009, 156:90-95.
20. Lin J.S. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev 2000, 4:471-503.
21. Lin J.S., Anaclet C., Sergeeva O.A., Haas H.L. The waking brain: an update. Cell Mol Life Sci 2011, 68:2499-2512.
22. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
23. Lin L., Wisor J., Shiba T., Taheri S., Yanai K., Wurts S., Lin X., Vitaterna M., Takahashi J., Lovenberg T.W., Koehl M., Uhl G., Nishino S., Mignot E. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 2002, 23:2203-2211.
24. Maloney K.J., Cape E.G., Gotman J., Jones B.E. High-frequency gamma electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat. Neuroscience 1997, 76:541-555.
25. Monti J.M. Involvement of histamine in the control of the waking state. Life Sci 1993, 53:1331-1338.
26. Morgan J.I., Curran T. Role of ion flux in the control of c-fos expression. Nature 1986, 322:552-555.
27. Murata Y., Tanimoto A., Wang K.Y., Tsutsui M., Sasaguri Y., De Corte F., Matsushita H. Granulocyte macrophage-colony stimulating factor increases the expression of histamine and histamine receptors in monocytes/macrophages in relation to arteriosclerosis. Arterioscler Thromb Vasc Biol 2005, 25:430-435.
28. Okamura N., Garau C., Duangdao D.M., Clark S.D., Jüngling K., Pape H.C., Reinscheid R.K. Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain. Neuropsychopharmacology 2011, 36:744-752.
29. Parmentier R., Anaclet C., Guhennec C., Brousseau E., Bricout D., Giboulot T., Bozyczko-Coyne D., Spiegel K., Ohtsu H., Williams M., Lin J.S. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol 2007, 73:1157-1171.
30. Parmentier R., Ohtsu H., Djebbara-Hannas Z., Valatx J.L., Watanabe T., Lin J.S. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 2002, 22:7695-7711.
31. Passani M.B., Lin J.S., Hancock A., Crochet S., Blandina P. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci 2004, 25:618-625.
32. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego. 4th ed.
33. Peng Y.L., Zhang J.N., Chang M., Li W., Han R.W., Wang R. Effects of central neuropeptide S in the mouse formalin test. Peptides 2010, 31:1878-1883.
34. Rizzi A., Vergura R., Marzola G., Ruzza C., Guerrini R., Salvadori S., Regoli D., Calo G. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol 2008, 154:471-479.
35. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007, 8:171-181.
36. Takahashi K., Lin J.S., Sakai K. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 2006, 26:10292-10298.
37. Takahashi K., Lin J.S., Sakai K. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse. Neuroscience 2008, 153:860-870.
38. Umehara H., Mizuguchi H., Mizukawa N., Matsumoto M., Takeda N., Senba E., Fukui H. Deprivation of anticipated food under scheduled feeding induces c-Fos expression in the caudal part of the arcuate nucleus of hypothalamus through histamine H1 receptors in rats: potential involvement of E3 subgroup of histaminergic neurons in tuberomammillary nucleus. Brain Res 2011, 1387:61-70.
39. Vanni-Mercier G., Gigout S., Debilly G., Lin J.S. Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. Behav Brain Res 2003, 144:227-241.
40. Xu Y.L., Gall C.M., Jackson V.R., Civelli O., Reinscheid R.K. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 2007, 500:84-102.
41. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., Brucher F.A., Zeng J., Ly N.K., Henriksen S.J., de Lecea L., Civelli O. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 2004, 43:487-497.
42. Yamanaka A., Tsujino N., Funahashi H., Honda K., Guan J.L., Wang Q.P., Tominaga M., Goto K., Shioda S., Sakurai T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 2002, 290:1237-1245.